Insights
Filter by Category
Case Studies
Articles
Medicines access: Unlocking the immense potential in cell and gene therapy
Despite several ground-breaking developments, pharmaceutical and biotech companies are often reluctant or unable to invest in cell and gene therapy. Here, we discuss the key challenges to access and how the potential of these innovative treatments can be unlocked.
Overcoming regulatory issues with investigational medicinal product labelling
For clinical trials operating across different counties, challenges with regulatory requirements must be overcome to avoid delays, while text translations need to be precise to ensure consistency globally while maintaining country-specific demands.
How to manage temperature-controlled shipments in unpredictable climate zones
Due to the increasing impact of climate change, drug packaging and shipping sectors have had to adapt by necessity. Clinical supplies expert Dr Simon Magness discusses how BAP Pharma adheres to the stringent requirements for shipping temperature-sensitive drugs around the globe amid increasingly challenging conditions.
How to ensure transparency in your clinical trial
Good communication is vital for running a successful clinical trial, and ensuring the clinical secondary packaging is both efficient and traceable is essential. Pharmaceutical Technology sat down with experts from BAP Pharma to discuss how transparency is key when considering your clinical trial supply strategy.
Harnessing the untapped potential of medicines access
Medicines access is a service that offers patients who have an unmet clinical need the ability to obtain treatment, which can often boost their quality of life, be life-extending or even lifesaving. However, there are multiple barriers to overcome when it comes to supply. Access services work through these hurdles to ensure minimal delays to the patient, while exploring the untapped opportunities available to pharmaceutical companies.
Downloadable White Papers
Enhancing medicines access: Overcoming Challenges and Maximsing Opportunities
Ensuring ongoing access to sought-after medicinal products for patients is becoming increasingly important, but many regulatory, logistical, and financial hurdles must be overcome. There is also a growing need to provide access to unlicensed, pre-approved drugs.
In this whitepaper, we will explore how pharma and biotech companies can devise efficient medicines access strategies and, in doing so, maximise the potential of their products while not only enabling continued access for patients with an unmet medical need but also reaching new patients on a global level.
Determining the optimum Packaging Design and Strategy for Clinical Trials
Effective packaging design and strategy are essential to the success of any clinical trial. Failure to adequately think through design and strategy in the early stages can cause delays and complications in the later stages, and in the worst cases it can stop your clinical trial in its tracks.
Yet for all its importance, clinical secondary packaging is often overlooked in the clinical trials. In this white paper, we will examine the process of developing and implementing an effective clinical secondary packaging strategy for clinical trials, which can offer much-needed flexibility to quickly adapt to changing circumstances and meet emerging demands.
Please complete the form below to access your copy of this .